Transcutaneous antigen delivery system.
Transcutaneous immunization refers to the topical application of antigens onto the epidermis. Transcutaneous immunization targeting the Langerhans cells of the skin has received much attention due to its safe, needle-free, and noninvasive antigen delivery. The skin has important immunological functions with unique roles for antigen-presenting cells such as epidermal Langerhans cells and dermal dendritic cells. In recent years, novel vaccine delivery strategies have continually been developed; however, transcutaneous immunization has not yet been fully exploited due to the penetration barrier represented by the stratum corneum, which inhibits the transport of antigens and adjuvants. Herein we review recent achievements in transcutaneous immunization, focusing on the various strategies for the enhancement of antigen delivery and vaccination efficacy.
Department of Medical Biotechnology, Soonchunhyang University, Asan, Korea. miyoung@sch.ac.kr
Mi-Young
MY
Lee
Meong-Cheol
MC
Shin
Victor C
VC
Yang
D000276:Adjuvants, Immunologic / Q000737:chemistry / Q000378:metabolism; D000279:Administration, Cutaneous; D000941:Antigens / Q000008:administration & dosage* / Q000276:immunology; D018899:CpG Islands; D004337:Drug Carriers / Q000737:chemistry*; D005098:Exotoxins / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D012867:Skin / Q000276:immunology; D051193:Toll-Like Receptors / Q000737:chemistry / Q000378:metabolism; D014611:Vaccination
D000276:Adjuvants, Immunologic; D000941:Antigens; D004337:Drug Carriers; D005098:Exotoxins; D051193:Toll-Like Receptors